Literature DB >> 9054269

Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.

S R Insler1, E J Kraenzler, J R Bartholomew, K Kottke-Marchant, B Lytle, N J Starr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9054269     DOI： 10.1097/00000542-199702000-00026

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  3 in total

Review 1.  Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.

Authors:  N Lubenow; A Greinacher
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

Review 2.  Danaparoid: a review of its use in thromboembolic and coagulation disorders.

Authors:  Tim Ibbotson; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.